
AbstractThe hydrogen bond in the [HDihH‐Fda]+ ion (HDih: 4,5‐dihydro‐1H‐imidazole, Fda: 1‐fluoro‐N,N‐dimethylmethaneamine) can be an ordinary single well hydrogen bond (HB) or a low barrier hydrogen bond (LBHB) depending on the orientation of the CH2F group in the Fda molecule. Both domains on the cluster's potential energy surface are well separated from each other by a 10 kcal/mol high barrier, which turns the CH2F group into a switch for the LBHB. The conformers with a LBHB are generally higher in energy than their counterparts with a standard HB, which suggests that the LBHB is not necessarily the more stable bond.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
